Clinical Trial Update: Benralizumab Exacerbation Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating benralizumab for asthma has completed. The provided excerpt does not include trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Asthma | Phase 4 | Status: COMPLETED